Nitration in neurodegeneration: Deciphering the "hows" "nYs"

Biochemistry

Volumn 46, Issue 25, 2007, Pages 7325-7336

  Reynolds, Matthew R ^a   Berry, Robert W ^a   Binder, Lester I ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL ENGINEERING; CONFORMATIONS; DISEASES; ELECTROSTATICS; NEUROLOGY; NITRATION;

ALZHEIMER'S DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; NEURODEGENERATION;

PROTEINS;

ALPHA SYNUCLEIN; HYDROGEN; MANGANESE SUPEROXIDE DISMUTASE; NEUROFILAMENT PROTEIN; NITRATE; PROTEIN; PROTEIN SUBUNIT; TYROSINE; TYROSINE 3 MONOOXYGENASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; HUMAN; NERVE DEGENERATION; NITRATION; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING;

ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; NITRATES; PARKINSON DISEASE; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUPEROXIDE DISMUTASE; TAU PROTEINS; TYROSINE 3-MONOOXYGENASE;

EID: 34250854596     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi700430y     Document Type: Article

References (100)

1. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., and Freeman, B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide, Proc. Natl. Acad. Sci. U.S.A. 87, 1620-1624.
2. Radi, R. (2004) Nitric oxide, oxidants, and protein tyrosine nitration, Proc. Natl. Acad. Sci. U.S.A. 101, 4003-4008.
3. Huie, R. E., and Padmaja, S. (1993) The reaction of no with superoxide, Free Radical Res. Commun. 18, 195-199.
4. Radi, R., Beckman, J. S., Bush, K. M., and Freeman, B. A. (1991) Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide, J. Biol. Chem. 266, 4244-4250.
5. Koppenol, W. H., Moreno, J. J., Pryor, W. A., Ischiropoulos, H., and Beckman, J. S. (1992) Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide, Chem. Res. Toxicol. 5, 834-842.
6. Ferrer-Sueta, G., Quijano, C., Alvarez, B., and Radi, R. (2002) Reactions of manganese porphyrins and manganese-superoxide dismutase with peroxynitrite, Methods Enzymol. 349, 23-37.
7. Squadrito, G. L., and Pryor, W. A. (1998) Oxidative chemistry of nitric oxide: The roles of superoxide, peroxynitrite, and carbon dioxide, Free Radical Biol. Med. 25, 392-403.
8. Gow, A., Duran, D., Thom, S. R., and Ischiropoulos, H. (1996) Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration, Arch. Biochem. Biophys. 333, 42-48.
9. Esteves, P. M., de M. Carneiro, J. W., Cardoso, S. P., Barbosa, A. G., Laali, K. K., Rasul, G., Prakash, G. K., and Olah, G. A. (2003) Unified mechanistic concept of electrophilic aromatic nitration: Convergence of computational results and experimental data, J. Am. Chem. Soc. 125, 4836-4849.
10. van der Vliet, A., Eiserich, J. P., Halliwell, B., and Cross, C. E. (1997) Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity, J. Biol. Chem. 272, 7617-7625.
11. Ischiropoulos, H. (2003) Biological selectivity and functional aspects of protein tyrosine nitration, Biochem. Biophys. Res. Commun. 305, 776-783.
12. Zhang, H., Joseph, J., Feix, J., Hogg, N., and Kalyanaraman, B. (2001) Nitration and oxidation of a hydrophobic tyrosine probe by peroxynitrite in membranes: Comparison with nitration and oxidation of tyrosine by peroxynitrite in aqueous solution, Biochemistry 40, 7675-7686.
13. MacMillan-Crow, L. A., Crow, J. P., and Thompson, J. A. (1998) Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues, Biochemistry 37, 1613-1622.
14. Yamakura, F., Taka, H., Fujimura, T., and Murayama, K. (1998) Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine, J. Biol. Chem. 273, 14085-14089.
15. Leigh, P. N., and Swash, M. (1991) Cytoskeletal pathology in motor neuron diseases, Adv. Neurol. 56, 115-124.
16. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H. X., et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature 362, 59-62.
17. Bruijn, L. I., Miller, T. M., and Cleveland, D. W. (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS, Annu. Rev. Neurosci. 27, 723-749.
18. Beckman, J. S. (1990) Ischaemic injury mediator, Nature 345, 27-28.
19. Reaume, A. G., Elliott, J. L., Hoffman, E. K., Kowall, N. W., Ferrante, R. J., Siwek, D. F., Wilcox, H. M., Flood, D. G., Beal, M. F., Brown, R. H., Jr., Scott, R. W., and Snider, W. D. (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury, Nat. Genet. 13, 43-47.
20. Borchelt, D. R., Lee, M. K., Slunt, H. S., Guarnieri, M., Xu, Z. S., Wong, P. C., Brown, R. H., Jr., Price, D. L., Sisodia, S. S., and Cleveland, D. W. (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity, Proc. Natl. Acad. Sci. U.S.A. 91, 8292-8296.
21. Crow, J. P., Sampson, J. B., Zhuang, Y., Thompson, J. A., and Beckman, J. S. (1997) Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite, J. Neurochem. 69, 1936-1944.
22. Tainer, J. A., Getzoff, E. D., Richardson, J. S., and Richardson, D. C. (1983) Structure and mechanism of copper, zinc superoxide dismutase, Nature 306, 284-287.
23. Beckman, J. S., Carson, M., Smith, C. D., and Koppenol, W. H. (1993) ALS, SOD and peroxynitrite, Nature 364, 584.
24. Yim, M. B., Kang, J. H., Yim, H. S., Kwak, H. S., Chock, P. B., and Stadtman, E. R. (1996) A gain-of-function of an amyotrophic lateral sclerosis-associated Cu, Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide, Proc. Natl. Acad. Sci. U.S.A. 93, 5709-5714.
25. Estevez, A. G., Crow, J. P., Sampson, J. B., Reiter, C., Zhuang, Y., Richardson, G. J., Tarpey, M. M., Barbeito, L., and Beckman, J. S. (1999) Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase, Science 286, 2498-2500.
26. Viglino, P., Scarpa, M., Coin, F., Rotilio, G., and Rigo, A. (1986) Oxidation of reduced Cu, Zn superoxide dismutase by molecular oxygen. A kinetic study, Biochem. J. 237, 305-308.
27. Ischiropoulos, H., Zhu, L., Chen, J., Tsai, M., Martin, J. C., Smith, C. D., and Beckman, J. S. (1992) Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase, Arch. Biochem. Biophys. 298, 431-437.
28. Forman, H. J., and Fridovich, I. (1973) On the stability of bovine superoxide dismutase. The effects of metals, J. Biol. Chem. 248, 2645-2649.
29. Alvarez, B., and Radi, R. (2003) Peroxynitrite reactivity with amino acids and proteins, Amino Acids 25, 295-311.
30. Matsuda, Y., Higashiyama, S., Kijima, Y., Suzuki, K., Kawano, K., Akiyama, M., Kawata, S., Tarui, S., Deutsch, H. F., and Taniguchi, N. (1990) Human liver manganese superoxide dismutase. Purification and crystallization, subunit association and sulfhydryl reactivity, Eur. J. Biochem. 194, 713-720.
31. Lebovitz, R. M., Zhang, H., Vogel, H., Cartwright, J., Jr., Dionne, L., Lu, N., Huang, S., and Matzuk, M. M. (1996) Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice, Proc. Natl. Acad. Sci. U.S.A. 93, 9782-9787.
32. Andreassen, O. A., Ferrante, R. J., Klivenyi, P., Klein, A. M., Shinobu, L. A., Epstein, C. J., and Beal, M. F. (2000) Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis, Ann. Neurol. 47, 447-455.
33. MacMillan-Crow, L. A., Crow, J. P., Kerby, J. D., Beckman, J. S., and Thompson, J. A. (1996) Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts, Proc. Natl. Acad. Sci. U.S.A. 93, 11853-11858.
34. Quijano, C., Hernandez-Saavedra, D., Castro, L., McCord, J. M., Freeman, B. A., and Radi, R. (2001) Reaction of peroxynitrite with Mn-superoxide dismutase. Role of the metal center in decomposition kinetics and nitration, J. Biol. Chem. 276, 11631-11638.
35. Whittaker, M. M., and Whittaker, J. W. (1997) Mutagenesis of a proton linkage pathway in Escherichia coli manganese superoxide dismutase, Biochemistry 36, 8923-8931.
36. Lah, M. S., Dixon, M. M., Pattridge, K. A., Stallings, W. C., Fee, J. A., and Ludwig, M. L. (1995) Structure-function in Escherichia coli iron superoxide dismutase: Comparisons with the manganese enzyme from Thermus thermophilus, Biochemistry 34, 1646-1660.
37. Beal, M. F., Ferrante, R. J., Browne, S. E., Matthews, R. T., Kowall, N. W., and Brown, R. H., Jr. (1997) Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis, Ann. Neurol. 42, 644-654.
38. Cassina, A., and Radi, R. (1996) Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport, Arch. Biochem. Biophys. 328, 309-316.
39. Ghafourifar, P., Schenk, U., Klein, S. D., and Richter, C. (1999) Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation, J. Biol. Chem. 274, 31185-31188.
40. Lupas, A. (1996) Coiled coils: New structures and new functions, Trends Biochem. Sci. 21, 375-382.
41. Heins, S., Wong, P. C., Muller, S., Goldie, K., Cleveland, D. W., and Aebi, U. (1993) The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation, J. Cell Biol. 123, 1517-1533.
42. Kawamura, Y., Dyck, P. J., Shimono, M., Okazaki, H., Tateishi, J., and Doi, H. (1981) Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis, J. Neuropathol. Exp. Neurol. 40, 667-675.
43. Collard, J. F., Cote, F., and Julien, J. P. (1995) Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis, Nature 375, 61-64.
44. Figlewicz, D. A., Krizus, A., Martinoli, M. G., Meininger, V., Dib, M., Rouleau, G. A., and Julien, J. P. (1994) Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis, Hum. Mol. Genet. 3, 1757-1761.
45. Chou, S. M., Wang, H. S., and Komai, K. (1996) Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: An immunohistochemical study, J. Chem. Neuroanat. 10, 249-258.
46. Crow, J. P., Ye, Y. Z., Strong, M., Kirk, M., Barnes, S., and Beckman, J. S. (1997) Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L, J. Neurochem. 69, 1945-1953.
47. Fuchs, E., and Weber, K. (1994) Intermediate filaments: Structure, dynamics, function, and disease, Annu. Rev. Biochem. 63, 345-382.
48. Lee, F. J., Liu, F., Pristupa, Z. B., and Niznik, H. B. (2001) Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis, FASEB J. 15, 916-926.
49. Kim, T. D., Paik, S. R., Yang, C. H., and Kim, J. (2000) Structural changes in α-synuclein affect its chaperone-like activity in vitro, Protein Sci. 9, 2489-2496.
50. Clayton, D. F., and George, J. M. (1999) Synucleins in synaptic plasticity and neurodegenerative disorders, J. Neurosci. Res. 58, 120-129.
51. Hashimoto, M., Rockenstein, E., Mante, M., Mallory, M., and Masliah, E. (2001) β-Synuclein inhibits α-synuclein aggregation: A possible role as an anti-parkinsonian factor, Neuron 32, 213-223.
52. Giasson, B. I., Duda, J. E., Murray, I. V., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., and Lee, V. M. (2000) Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions, Science 290, 985-989.
53. Good, P. F., Hsu, A., Werner, P., Perl, D. P., and Olanow, C. W. (1998) Protein nitration in Parkinson's disease, J. Neuropathol. Exp. Neurol. 57, 338-342.
54. Klivenyi, P., St Clair, D., Wermer, M., Yen, H. C., Oberley, T., Yang, L., and Flint Beal, M. (1998) Manganese superoxide dismutase overexpression attenuates MPTP toxicity, Neurobiol. Dis. 5, 253-258.
55. Przedborski, S., Kostic, V., Jackson-Lewis, V., Naini, A. B., Simonetti, S., Fahn, S., Carlson, E., Epstein, C. J., and Cadet, J. L. (1992) Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity, J. Neurosci. 12, 1658-1667.
56. Zhang, J., Graham, D. G., Montine, T. J., and Ho, Y. S. (2000) Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase, J. Neuropathol. Exp. Neurol. 59, 53-61.
57. Schulz, J. B., Matthews, R. T., Muqit, M. M., Browne, S. E., and Beal, M. F. (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice, J. Neurochem. 64, 936-939.
58. Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., and Przedborski, S. (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease, Nat. Med. 5, 1403-1409.
59. Przedborski, S., Chen, Q., Vila, M., Giasson, B. I., Djaldatti, R., Vukosavic, S., Souza, J. M., Jackson-Lewis, V., Lee, V. M., and Ischiropoulos, H. (2001) Oxidative post-translational modifications of α-synuclein in the l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease, J. Neurochem. 76, 637-640.
60. Souza, J. M., Giasson, B. I., Chen, Q., Lee, V. M., and Ischiropoulos, H. (2000) Dityrosine cross-linking promotes formation of stable α-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies, J. Biol. Chem. 275, 18344-18349.
61. Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., and Lansbury, P. T., Jr. (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded, Biochemistry 35, 13709-13715.
62. Zhu, M., and Fink, A. L. (2003) Lipid binding inhibits α-synuclein fibril formation, J. Biol. Chem. 278, 16873-16877.
63. Trostchansky, A., Lind, S., Hodara, R., Oe, T., Blair, I. A., Ischiropoulos, H., Rubbo, H., and Souza, J. M. (2006) Interaction with phospholipids modulates α-synuclein nitration and lipid-protein adduct formation, Biochem. J. 393, 343-349.
64. El-Agnaf, O. M., Jakes, R., Curran, M. D., Middleton, D., Ingenito, R., Bianchi, E., Pessi, A., Neill, D., and Wallace, A. (1998) Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments, FEBS Lett. 440, 71-75.
65. Uversky, V. N., Yamin, G., Munishkina, L. A., Karymov, M. A., Millett, I. S., Doniach, S., Lyubchenko, Y. L., and Fink, A. L. (2005) Effects of nitration on the structure and aggregation of α-synuclein, Brain Res. Mol. Brain Res. 134, 84-102.
66. Hodara, R., Norris, E. H., Giasson, B. I., Mishizen-Eberz, A. J., Lynch, D. R., Lee, V. M., and Ischiropoulos, H. (2004) Functional consequences of α-synuclein tyrosine nitration: Diminished binding to lipid vesicles and increased fibril formation, J. Biol. Chem. 279, 47746-47753.
67. Yamin, G., Uversky, V. N., and Fink, A. L. (2003) Nitration inhibits fibrillation of human α-synuclein in vitro by formation of soluble oligomers, FEBS Lett. 542, 147-152.
68. Volles, M. J., and Lansbury, P. T., Jr. (2002) Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism, Biochemistry 41, 4595-4602.
69. Pakkenberg, B., Moller, A., Gundersen, H. J., Mouritzen Dam, A., and Pakkenberg, H. (1991) The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method, J. Neurol., Neurosurg. Psychiatry 54, 30-33.
70. Nagatsu, T. (1990) Change of tyrosine hydroxylase in the parkinsonian brain and in the brain of MPTP-treated mice as revealed by homospecific activity, Neurochem. Res. 15, 425-429.
71. Ara, J., Przedborski, S., Naini, A. B., Jackson-Lewis, V., Trifiletti, R. R., Horwitz, J., and Ischiropoulos, H. (1998) Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Proc. Natl. Acad. Sci. U.S.A. 95, 7659-7663.
72. Tipton, K. F., and Singer, T. P. (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds, J. Neurochem. 61, 1191-1206.
73. Klaidman, L. K., Adams, J. D., Jr., Leung, A. C., Kim, S. S., and Cadenas, E. (1993) Redox cycling of MPP+: Evidence for a new mechanism involving hydride transfer with xanthine oxidase, aldehyde dehydrogenase, and lipoamide dehydrogenase, Free Radical Biol. Med. 15, 169-179.
74. Goodwill, K. E., Sabatier, C., Marks, C., Raag, R., Fitzpatrick, P. F., and Stevens, R. C. (1997) Crystal structure of tyrosine hydroxylase at 2.3 Å and its implications for inherited neurodegenerative diseases, Nat. Struct. Biol. 4, 578-585.
75. Blanchard-Fillion, B., Souza, J. M., Friel, T., Jiang, G. C., Vrana, K., Sharov, V., Barron, L., Schoneich, C., Quijano, C., Alvarez, B., Radi, R., Przedborski, S., Fernando, G. S., Horwitz, J., and Ischiropoulos, H. (2001) Nitration and inactivation of tyrosine hydroxylase by peroxynitrite, J. Biol. Chem. 276, 46017-46023.
76. Kidd, M. (1963) Paired helical filaments in electron microscopy of Alzheimer's disease, Nature 197, 192-193.
77. Garcia-Sierra, F., Ghoshal, N., Quinn, B., Berry, R. W., and Binder, L. I. (2003) Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease, J. Alzheimer's Dis. 5, 65-77.
78. Carmel, G., Mager, E. M., Binder, L. I., and Kuret, J. (1996) The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology, J. Biol. Chem. 271, 32789-32795.
79. Gamblin, T. C., Berry, R. W., and Binder, L. I. (2003) Tau polymerization: Role of the amino terminus, Biochemistry 42, 2252-2257.
80. Gamblin, T. C., Berry, R. W., and Binder, L. I. (2003) Modeling tau polymerization in vitro: A review and synthesis, Biochemistry 42, 15009-15017.
81. von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E. M., and Mandelkow, E. (2000) Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming β structure, Proc. Natl. Acad. Sci. U.S.A. 97, 5129-5134.
82. Berry, R. W., Abraha, A., Lagalwar, S., LaPointe, N., Gamblin, T. C., Cryns, V. L., and Binder, L. I. (2003) Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment, Biochemistry 42, 8325-8331.
83. Reynolds, M. R., Berry, R. W., and Binder, L. I. (2005) Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: Implications for Alzheimer's disease, Biochemistry 44, 1690-1700.
84. Reynolds, M. R., Berry, R. W., and Binder, L. I. (2005) Site-specific nitration differentially influences tau assembly in vitro, Biochemistry 44, 13997-14009.
85. Reynolds, M. R., Lukas, T. J., Berry, R. W., and Binder, L. I. (2006) Peroxynitrite-mediated tau modifications stabilize preformed filaments and destabilize microtubules through distinct mechanisms, Biochemistry 45, 4314-4326.
86. Wilson, D. M., and Binder, L. I. (1997) Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease, Am. J. Pathol. 150, 2181-2195.
87. King, M. E., Ahuja, V., Binder, L. I., and Kuret, J. (1999) Ligand-dependent tau filament formation: Implications for Alzheimer's disease progression, Biochemistry 38, 14851-14859.
88. Kuret, J., Chirita, C. N., Congdon, E. E., Kannanayakal, T., Li, G., Necula, M., Yin, H., and Zhong, Q. (2005) Pathways of tau fibrillization, Biochim. Biophys. Acta 1739, 167-178.
89. Gray, E. G., Paula-Barbosa, M., and Roher, A. (1987) Alzheimer's disease: Paired helical filaments and cytomembranes, Neuropathol. Appl. Neurobiol. 13, 91-110.
90. Biernat, J., Gustke, N., Drewes, G., Mandelkow, E. M., and Mandelkow, E. (1993) Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding, Neuron 11, 153-163.
91. Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., and Perry, G. (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease, J. Neurosci. 17, 2653-2657.
92. Horiguchi, T., Uryu, K., Giasson, B. I., Ischiropoulos, H., LightFoot, R., Bellmann, C., Richter-Landsberg, C., Lee, V. M., and Trojanowski, J. Q. (2003) Nitration of tau protein is linked to neurodegeneration in tauopathies, Am. J. Pathol. 163, 1021-1031.
93. Reynolds, M. R., Reyes, J. F., Fu, Y., Bigio, E. H., Guillozet-Bongaarts, A. L., Berry, R. W., and Binder, L. I. (2006) Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies, J. Neurosci. 26, 10636-10645.
94. Alonso, A. C., Grundke-Iqbal, I., and Iqbal, K. (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules, Nat. Med. 2, 783-787.
95. Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., and Lee, V. M. (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding, Neuron 10, 1089-1099.
96. Oosawa, F., and Kasai, M. (1962) A theory of linear and helical aggregations of macromolecules, J. Mol. Biol. 4, 10-21.
97. Brennan, M. L., Wu, W., Fu, X., Shen, Z., Song, W., Frost, H., Vadseth, C., Narine, L., Lenkiewicz, E., Borchers, M. T., Lusis, A. J., Lee, J. J., Lee, N. A., Abu-Soud, H. M., Ischiropoulos, H., and Hazen, S. L. (2002) A tale of two controversies: Defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species, J. Biol. Chem. 277, 17415-17427.
98. Kong, S. K., Yim, M. B., Stadtman, E. R., and Chock, P. B. (1996) Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: Lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide, Proc. Natl. Acad. Sci. U.S.A. 93, 3377-3382.
99. Lee, G., Thangavel, R., Sharma, V. M., Litersky, J. M., Bhaskar, K., Fang, S. M., Do, L. H., Andreadis, A., Van Hoesen, G., and Ksiezak-Reding, H. (2004) Phosphorylation of tau by fyn: Implications for Alzheimer's disease, J. Neurosci. 24, 2304-2312.
100. Ohmori, H., Oka, M., Nishikawa, Y., Shigemitsu, H., Takeuchi, M., Magari, M., and Kanayama, N. (2005) Immunogenicity of autologous IgG bearing the inflammation-associated marker 3-nitrotyrosine, Immunol. Lett. 96, 47-54.